Articles By Liisa Vexler

  1. FDA Encouraged To Withdraw Its Approval Of 'Supercharged' Painkiller 3/17/2014

    A number of health care agencies would like the U.S. Food and Drug Administration (FDA) to reconsider its approval of Zohydro, a painkiller described as ‘supercharged’.

  2. Pfizer Recall Of Effexor Due To Potential Contamination 3/12/2014

    Pharmaceutical company, Pfizer has asked for a recall of Effexor (venlafaxine HCI), antidepressant medication, after claims of potential contamination.

  3. Recall Of Etomidate Intravenous Injection Anaesthetic By Mylan Due To Contamination 3/5/2014

    Ten lots of the anesthesia etomidate injection have been recalled by the India-based company Mylan Pharmaceuticals because some of the vials were inadvertently contaminated with pieces of shipping labels. 

  4. Government's Pharmaceutical Health Budget Receiving Pressure from High Blood Pressure and Diabetes 3/4/2014

    The prevalence of non-communicable diseases (NCDs) in the Pacific is creating particular challenges to health, finance and policy in the region of Vanuatu and surrounding countries. The NCDs of particular concern are type 2 diabetes and cardiovascular disease/hypertension.

  5. Andromeda Seeks Purchase From Unnamed American Drug Firm 2/28/2014

    Hundreds of millions of dollars are at stake for the purchase of Andromeda Biotech to an American pharmaceutical company.

  6. Eyes On Indian Pharmaceutical Companies As They Attempt To Raise Consumer Confidence 2/25/2014

    India is slowly making its way to being one of the biggest exporters of the American drug supply chain.

  7. Chairman Of Teva Expected To Retire This Year 2/21/2014

    Phillip Frost, chairman of the board of directors of Teva Pharmaceutical Industries Ltd. since March 2010, may retire before the end of the year if a suitable successor can be found.

  8. Companies in Japan Are Making Changes To Preserve The Environment 2/21/2014

    Otsuka Pharmaceuticals and the Kawasaki City Water Department, both based in the Kakegawa province of Japan, have made changes to their processes in order to protect the environment.

  9. Success Of New Drug For Huntington's Disease Boosts Prana's Share Price 2/21/2014

    The price of shares in the Australian-based company Prana Biotechnology Ltd. jumped by about 31% after the announcement that its new drug, PBT2, gave an improvement in cognitive function in patients with Huntington's disease.

  10. New Heat-Stable Meningitis Vaccine Enables African Vaccination Program to Reach Remote Areas 2/21/2014

    MenAfrVac is a revolutionary new meningitis vaccine that does not need to be refrigerated constantly and is viable for up to 4 days at temperatures as high as 39°C.